Replies to post #17196 on Biotech Values

[randychub]

gtcb - " I would not read a lot into this nuance."

I am not so quick to agree with you on this. I have a call in to discuss it with Tom.

"Moreover, I’ve never been especially concerned about GTC’s ability to find a development and commercialization partner for ATryn."

Provided they get the EMEA to approve atryn I agree.

If they get a partner before the emea decision in Feb, the shares I own will be paid for by the shares I sell.

R